BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Orasan OH, Ciulei G, Cozma A, Sava M, Dumitrascu DL. Hyaluronic acid as a biomarker of fibrosis in chronic liver diseases of different etiologies. Clujul Med 2016;89:24-31. [PMID: 27004022 DOI: 10.15386/cjmed-554] [Cited by in Crossref: 10] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
Number Citing Articles
1 Dzudzor B, Hammond H, Tachi K, Alisi A, Vento S, Gyasi RK, Aheto JMK. Serum 25-hydroxyvitamin D and hyaluronic acid levels as markers of fibrosis in patients with chronic liver disease at the main tertiary referral hospital in Ghana: A case-control study design. Health Sci Rep 2023;6:e1101. [PMID: 36789398 DOI: 10.1002/hsr2.1101] [Reference Citation Analysis]
2 Kihara T, Sugihara T, Ikeda S, Matsuki Y, Nagahara T, Oyama K, Okano J, Isomoto H. A case of portal hypertension complicated with <i>de novo</i> acute myeloid leukemia. Acta hepatologica Japonica 2022;63:409-416. [DOI: 10.2957/kanzo.63.409] [Reference Citation Analysis]
3 Mostafa TM, El-Azab GA, Badra GA, Abdelwahed AS, Elsayed AA. Effect of Candesartan and Ramipril on Liver Fibrosis in Patients with Chronic Hepatitis C Viral Infection: A Randomized Controlled Prospective Study. Curr Ther Res Clin Exp 2021;95:100654. [PMID: 34925649 DOI: 10.1016/j.curtheres.2021.100654] [Reference Citation Analysis]
4 Rewisha E, Salman T, Alhaddad O, Raia GA, Naguib M, Rashad S, Abdelfattah A, Metwally K, Abdelsameea E. Hyaluronic acid as a potential marker for assessment of fibrosis regression after direct acting antiviral drugs in chronic hepatitis C patients. Clin Exp Hepatol 2021;7:320-7. [PMID: 34712835 DOI: 10.5114/ceh.2021.109293] [Reference Citation Analysis]
5 Murtha-Lemekhova A, Fuchs J, Ghamarnejad O, Nikdad M, Probst P, Hoffmann K. Influence of cytokines, circulating markers and growth factors on liver regeneration and post-hepatectomy liver failure: a systematic review and meta-analysis. Sci Rep 2021;11:13739. [PMID: 34215781 DOI: 10.1038/s41598-021-92888-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
6 Lin CY, Adhikary P, Cheng K. Cellular protein markers, therapeutics, and drug delivery strategies in the treatment of diabetes-associated liver fibrosis. Adv Drug Deliv Rev 2021;174:127-39. [PMID: 33857552 DOI: 10.1016/j.addr.2021.04.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
7 Kim LB, Putyatina AN, Russkikh GS, Shkurupy VA. Content of the Major Extracellular Matrix Components of the Liver and Lungs in Mice with Chronic BCG-Granulomatosis Treated with Liposome-Encapsulated Dextrazide. Bull Exp Biol Med 2021;170:453-7. [PMID: 33725244 DOI: 10.1007/s10517-021-05086-7] [Reference Citation Analysis]
8 Kulebina EA, Surkov AN, Fisenko AP, Potapov AS, Alyabeva NM, Zubkova IV, Zhuzhula AA. The informative value of assessment of direct serum biomarkers for diagnosis of various stages of liver fibrosis in children. RPJ 2021;24:4-11. [DOI: 10.46563/1560-9561-2021-24-1-4-11] [Reference Citation Analysis]
9 Feng S, Wang Z, Zhao Y, Tao C. Wisteria floribunda agglutinin-positive Mac-2-binding protein as a diagnostic biomarker in liver cirrhosis: an updated meta-analysis. Sci Rep 2020;10:10582. [PMID: 32601332 DOI: 10.1038/s41598-020-67471-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
10 Zirnis AE, Straume Z, Bērziņa R, Māliņa-bambīte J, Derovs A, Zeltiņa I. Establishing Cut-Offs for Non-Invasive Liver Tests to Detect Cirrhosis at a High Sensitivity. Proceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences. 2020;74:118-124. [DOI: 10.2478/prolas-2020-0019] [Reference Citation Analysis]
11 Kupčová V, Fedelešová M, Bulas J, Kozmonová P, Turecký L. Overview of the Pathogenesis, Genetic, and Non-Invasive Clinical, Biochemical, and Scoring Methods in the Assessment of NAFLD. Int J Environ Res Public Health 2019;16:E3570. [PMID: 31554274 DOI: 10.3390/ijerph16193570] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
12 Tamura M, Ohta H, Shimbo G, Osuga T, Sasaki N, Morishita K, Kagawa Y, Takiguchi M. Usefulness of noninvasive shear wave elastography for the assessment of hepatic fibrosis in dogs with hepatic disease. J Vet Intern Med 2019;33:2067-74. [PMID: 31461576 DOI: 10.1111/jvim.15598] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
13 Nagy N, Sunkari VG, Kaber G, Hasbun S, Lam DN, Speake C, Sanda S, McLaughlin TL, Wight TN, Long SR, Bollyky PL. Hyaluronan levels are increased systemically in human type 2 but not type 1 diabetes independently of glycemic control. Matrix Biol 2019;80:46-58. [PMID: 30196101 DOI: 10.1016/j.matbio.2018.09.003] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 5.3] [Reference Citation Analysis]
14 Huang Y, Xu Y, Huang Y, Sun F, Tian H, Hu N, Shi L, Hua H. Identification of newly developed advanced schistosomiasis with MALDI-TOF mass spectrometry and ClinProTools analysis. Parasite 2019;26:33. [PMID: 31166908 DOI: 10.1051/parasite/2019032] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
15 Nallagangula KS, Nagaraj SK, Venkataswamy L, Chandrappa M. Liver fibrosis: a compilation on the biomarkers status and their significance during disease progression. Future Sci OA 2018;4:FSO250. [PMID: 29255622 DOI: 10.4155/fsoa-2017-0083] [Cited by in Crossref: 68] [Cited by in F6Publishing: 73] [Article Influence: 11.3] [Reference Citation Analysis]
16 Al-Daghri NM, Batzel JJ, Burgmann H, Carbone F, Charmandari E, Chrousos GP, Distelmaier K, Cvirn G, Dullaart RPF, Dumitrascu DL, Esteve-Pastor MA, Gervasini G, Goliasch G, Goswami N, Gruppen EG, Hernández-Mijares A, Kalantaridou SN, Krause R, Latini R, Makrigiannakis A, Marín F, Masson S, Montecucco F, Ndrepepa G, Nicolaides NC, Novelli D, Orasan OH, Qorbani M, Ratzinger F, Roessler A, Sabico S, Sciatti E, Stefanaki C, Stoner L, Tabatabaei-Malazy O, Tatar E, Toz H, Uslu A, Victor VM, Vizzardi E. Research update for articles published in EJCI in 2015. Eur J Clin Invest 2017;47:775-88. [PMID: 28960328 DOI: 10.1111/eci.12819] [Reference Citation Analysis]
17 Taibi L, Guéchot J. Évaluation non invasive de la fibrose hépatique. Revue Francophone des Laboratoires 2017;2017:38-44. [DOI: 10.1016/s1773-035x(17)30117-x] [Reference Citation Analysis]